557.33 USD
-0.8 (-0.14%)
We assign a fundamental rating of 7 out of 10 to ISRG. ISRG was compared to 187 industry peers in the Health Care Equipment & Supplies industry. ISRG has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. ISRG is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings would make ISRG suitable for growth and quality investing!
1. Profitability
1.1 Basic Checks
ISRG had positive earnings in the past year.
In the past year ISRG had a positive cash flow from operations.
Each year in the past 5 years ISRG has been profitable.
In the past 5 years ISRG always reported a positive cash flow from operatings.
1.2 Ratios
ISRG has a Return On Assets of 14.19%. This is amongst the best in the industry. ISRG outperforms 96.26% of its industry peers.
ISRG's Return On Equity of 16.12% is amongst the best of the industry. ISRG outperforms 91.44% of its industry peers.
Looking at the Return On Invested Capital, with a value of 14.96%, ISRG belongs to the top of the industry, outperforming 95.19% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ISRG is above the industry average of 8.81%.
The 3 year average ROIC (12.20%) for ISRG is below the current ROIC(14.96%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.19% | ||
| ROE | 16.12% | ||
| ROIC | 14.96% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)12.2%
ROIC(5y)11.86%
1.3 Margins
ISRG has a better Profit Margin (28.58%) than 96.79% of its industry peers.
ISRG's Profit Margin has declined in the last couple of years.
The Operating Margin of ISRG (29.44%) is better than 96.79% of its industry peers.
ISRG's Operating Margin has declined in the last couple of years.
ISRG has a better Gross Margin (66.38%) than 69.52% of its industry peers.
In the last couple of years the Gross Margin of ISRG has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 29.44% | ||
| PM (TTM) | 28.58% | ||
| GM | 66.38% |
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ISRG is still creating some value.
ISRG has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ISRG has more shares outstanding
There is no outstanding debt for ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
There is no outstanding debt for ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | N/A |
ROIC/WACC1.7
WACC8.81%
2.3 Liquidity
ISRG has a Current Ratio of 4.97. This indicates that ISRG is financially healthy and has no problem in meeting its short term obligations.
ISRG's Current ratio of 4.97 is fine compared to the rest of the industry. ISRG outperforms 77.54% of its industry peers.
A Quick Ratio of 4.20 indicates that ISRG has no problem at all paying its short term obligations.
With a decent Quick ratio value of 4.20, ISRG is doing good in the industry, outperforming 77.01% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.97 | ||
| Quick Ratio | 4.2 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 28.12% over the past year.
ISRG shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.48% yearly.
The Revenue has grown by 22.18% in the past year. This is a very strong growth!
ISRG shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.27% yearly.
EPS 1Y (TTM)28.12%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%30.43%
Revenue 1Y (TTM)22.18%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%22.91%
3.2 Future
The Earnings Per Share is expected to grow by 15.47% on average over the next years. This is quite good.
Based on estimates for the next years, ISRG will show a quite strong growth in Revenue. The Revenue will grow by 14.12% on average per year.
EPS Next Y20.12%
EPS Next 2Y16.31%
EPS Next 3Y15.91%
EPS Next 5Y15.47%
Revenue Next Year21.33%
Revenue Next 2Y18.1%
Revenue Next 3Y16.47%
Revenue Next 5Y14.12%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 64.73, the valuation of ISRG can be described as expensive.
67.38% of the companies in the same industry are more expensive than ISRG, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.29, ISRG is valued quite expensively.
ISRG is valuated quite expensively with a Price/Forward Earnings ratio of 56.20.
Based on the Price/Forward Earnings ratio, ISRG is valued a bit cheaper than 68.98% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.51, ISRG is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 64.73 | ||
| Fwd PE | 56.2 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ISRG is valued a bit cheaper than 66.31% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ISRG is valued a bit cheaper than the industry average as 70.59% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 86.99 | ||
| EV/EBITDA | 54.92 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ISRG does not grow enough to justify the current Price/Earnings ratio.
ISRG has an outstanding profitability rating, which may justify a higher PE ratio.
ISRG's earnings are expected to grow with 15.91% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.22
PEG (5Y)5.64
EPS Next 2Y16.31%
EPS Next 3Y15.91%
5. Dividend
5.1 Amount
ISRG does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:ISRG (12/10/2025, 9:47:02 AM)
557.33
-0.8 (-0.14%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners88.16%
Inst Owner Change3.08%
Ins Owners0.45%
Ins Owner Change1.29%
Market Cap197.57B
Revenue(TTM)9.61B
Net Income(TTM)2.75B
Analysts78
Price Target613.44 (10.07%)
Short Float %2.12%
Short Ratio3.19
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.16%
Min EPS beat(2)11.61%
Max EPS beat(2)18.71%
EPS beat(4)4
Avg EPS beat(4)13.53%
Min EPS beat(4)3.05%
Max EPS beat(4)20.76%
EPS beat(8)8
Avg EPS beat(8)11%
EPS beat(12)11
Avg EPS beat(12)7.6%
EPS beat(16)13
Avg EPS beat(16)5.75%
Revenue beat(2)2
Avg Revenue beat(2)2%
Min Revenue beat(2)1.84%
Max Revenue beat(2)2.17%
Revenue beat(4)4
Avg Revenue beat(4)2.55%
Min Revenue beat(4)1.09%
Max Revenue beat(4)5.12%
Revenue beat(8)5
Avg Revenue beat(8)1.17%
Revenue beat(12)6
Avg Revenue beat(12)0.55%
Revenue beat(16)8
Avg Revenue beat(16)0.31%
PT rev (1m)0.78%
PT rev (3m)2.68%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.25%
EPS NY rev (1m)0.16%
EPS NY rev (3m)5.77%
Revenue NQ rev (1m)0.04%
Revenue NQ rev (3m)1.69%
Revenue NY rev (1m)0.14%
Revenue NY rev (3m)1.35%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 64.73 | ||
| Fwd PE | 56.2 | ||
| P/S | 20.55 | ||
| P/FCF | 86.99 | ||
| P/OCF | 66.73 | ||
| P/B | 11.59 | ||
| P/tB | 11.83 | ||
| EV/EBITDA | 54.92 |
EPS(TTM)8.61
EY1.54%
EPS(NY)9.92
Fwd EY1.78%
FCF(TTM)6.41
FCFY1.15%
OCF(TTM)8.35
OCFY1.5%
SpS27.11
BVpS48.07
TBVpS47.09
PEG (NY)3.22
PEG (5Y)5.64
Graham Number96.5
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.19% | ||
| ROE | 16.12% | ||
| ROCE | 16.61% | ||
| ROIC | 14.96% | ||
| ROICexc | 29.62% | ||
| ROICexgc | 30.86% | ||
| OM | 29.44% | ||
| PM (TTM) | 28.58% | ||
| GM | 66.38% | ||
| FCFM | 23.63% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)12.2%
ROIC(5y)11.86%
ROICexc(3y)18.44%
ROICexc(5y)19.03%
ROICexgc(3y)19.29%
ROICexgc(5y)20.12%
ROCE(3y)13.54%
ROCE(5y)13.16%
ROICexgc growth 3Y-7.59%
ROICexgc growth 5Y-7%
ROICexc growth 3Y-6.87%
ROICexc growth 5Y-6.06%
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
F-Score8
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 111.36% | ||
| Cap/Sales | 7.17% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 85.84% | ||
| Profit Quality | 82.69% | ||
| Current Ratio | 4.97 | ||
| Quick Ratio | 4.2 | ||
| Altman-Z | N/A |
F-Score8
WACC8.81%
ROIC/WACC1.7
Cap/Depr(3y)197.35%
Cap/Depr(5y)162.98%
Cap/Sales(3y)12.27%
Cap/Sales(5y)10.16%
Profit Quality(3y)56.77%
Profit Quality(5y)75.99%
High Growth Momentum
Growth
EPS 1Y (TTM)28.12%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%30.43%
EPS Next Y20.12%
EPS Next 2Y16.31%
EPS Next 3Y15.91%
EPS Next 5Y15.47%
Revenue 1Y (TTM)22.18%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%22.91%
Revenue Next Year21.33%
Revenue Next 2Y18.1%
Revenue Next 3Y16.47%
Revenue Next 5Y14.12%
EBIT growth 1Y36.82%
EBIT growth 3Y8.76%
EBIT growth 5Y11.37%
EBIT Next Year45.62%
EBIT Next 3Y24.72%
EBIT Next 5Y20.46%
FCF growth 1Y80.69%
FCF growth 3Y-9.1%
FCF growth 5Y2.14%
OCF growth 1Y46.32%
OCF growth 3Y4.95%
OCF growth 5Y8.61%
INTUITIVE SURGICAL INC / ISRG FAQ
Can you provide the ChartMill fundamental rating for INTUITIVE SURGICAL INC?
ChartMill assigns a fundamental rating of 7 / 10 to ISRG.
Can you provide the valuation status for INTUITIVE SURGICAL INC?
ChartMill assigns a valuation rating of 4 / 10 to INTUITIVE SURGICAL INC (ISRG). This can be considered as Fairly Valued.
How profitable is INTUITIVE SURGICAL INC (ISRG) stock?
INTUITIVE SURGICAL INC (ISRG) has a profitability rating of 8 / 10.
What is the financial health of INTUITIVE SURGICAL INC (ISRG) stock?
The financial health rating of INTUITIVE SURGICAL INC (ISRG) is 7 / 10.